Life expectancy and cardiovascular mortality in persons with schizophrenia
Top Cited Papers
- 1 March 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Psychiatry
- Vol. 25 (2), 83-88
- https://doi.org/10.1097/yco.0b013e32835035ca
Abstract
To assess the impact of cardiovascular disease on the excess mortality and shortened life expectancy in schizophrenic patients. Patients with schizophrenia have two-fold to three-fold higher mortality rates compared with the general population, corresponding to a 10-25-year reduction in life expectancy. Although the mortality rate from suicide is high, natural causes of death account for a greater part of the reduction in life expectancy. The reviewed studies suggest four main reasons for the excess mortality and reduced life expectancy. First, persons with schizophrenia tend to have suboptimal lifestyles including unhealthy diets, excessive smoking and alcohol use, and lack of exercise. Second, antipsychotic drugs may have adverse effects. Third, physical illnesses in persons with schizophrenia are common, but diagnosed late and treated insufficiently. Lastly, the risk of suicide and accidents among schizophrenic patients is high. Schizophrenia is associated with a substantially higher mortality and curtailed life expectancy partly caused by modifiable risk factors.Keywords
This publication has 25 references indexed in Scilit:
- Life expectancy among persons with schizophrenia or bipolar affective disorderSchizophrenia Research, 2011
- Increased Risks of Acute Organ Dysfunction and Mortality in Intensive Care Unit Patients With SchizophreniaPsychosomatic Medicine, 2011
- The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up studySchizophrenia Research, 2011
- Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in LondonPLOS ONE, 2011
- Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)American Journal of Psychiatry, 2011
- Lower Mortality Among Stroke Patients With Schizophrenia: A Nationwide Population-Based StudyPsychosomatic Medicine, 2011
- Increased Mortality Among Patients Admitted With Major Psychiatric DisordersThe Journal of Clinical Psychiatry, 2007
- Schizophrenia and increased risks of cardiovascular diseaseAmerican Heart Journal, 2005
- Mortality and causes of death in schizophrenia in Stockholm County, SwedenSchizophrenia Research, 2000
- Excess mortality of mental disorderThe British Journal of Psychiatry, 1998